Processing

Please wait...

Settings

Settings

1. WO2000040089 - TARGETED TRANSSCLERAL CONTROLLED RELEASE DRUG DELIVERY TO THE RETINA AND CHOROID

Publication Number WO/2000/040089
Publication Date 13.07.2000
International Application No. PCT/US2000/000207
International Filing Date 05.01.2000
Chapter 2 Demand Filed 10.07.2000
IPC
A61K 38/16 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K 16/24 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
24against cytokines, lymphokines or interferons
CPC
A61K 2039/505
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
505comprising antibodies
A61K 38/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K 16/24
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
24against cytokines, lymphokines or interferons
Applicants
  • MASSACHUSETTS EYE AND EAR INFIRMARY [US/US]; 243 Charles Street Boston, MA 02114, US
Inventors
  • ADAMIS, Anthony, P.; US
  • GRAGOUDAS, Evangelos, S.; US
  • MILLER, Joan, W.; US
Agents
  • CLARK, Paul, T.; Clark & Elbing, LLP 176 Federal Street Boston, MA 02110-2214, US
Priority Data
60/114,90505.01.1999US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TARGETED TRANSSCLERAL CONTROLLED RELEASE DRUG DELIVERY TO THE RETINA AND CHOROID
(FR) ADMINISTRATION CIBLEE DE MEDICAMENT A LIBERATION REGULEE VERS LA RETINE ET LA CHOROIDE A TRAVERS LA SCLEROTIQUE
Abstract
(EN)
The invention provides methods for delivering a therapeutic or diagnostic agent to the eye of a mammal. The method involves contacting sclera with a therapeutic or diagnostic agent so as to permit its passage through the sclera into the choroidal and retinal tissues. The sclera may be contacted with a therapeutic or diagnostic agent together with a device for enhancing transport of the agent through the sclera.
(FR)
L'invention concerne des méthodes d'administration d'un agent thérapeutique ou diagnostique dans l'oeil d'un mammifère. Ladite méthode consiste à mettre la sclérotique en contact avec un agent thérapeutique ou diagnostique de manière à permettre son passage à travers la sclérotique dans les tissus rétiniens et choroïdiens. La mise en contact de la sclérotique avec un agent thérapeutique ou diagnostique peut être effectuée à l'aide d'un dispositif permettant d'améliorer l'acheminement de l'agent à travers la sclérotique.
Also published as
Latest bibliographic data on file with the International Bureau